Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Veeda Clinical Research Acquires European CRO, Heads | Contract Pharma

What are you searching for?

Sign in
Breaking News

Veeda Clinical Research Acquires European CRO, Heads

Expands Veeda’s global reach and adds capabilities for contract research services from discovery to clinical development and post commercial launch.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Veeda Clinical Research Ltd., a full-service contract research organization (CRO), has acquired Heads, a privately held European CRO specializing in conducting clinical trials in oncology. Heads has an operational presence in 25 strategic locations across Europe, North America and the Asia Pacific region. The acquisition expands Veeda’s global reach and adds integrated capabilities for contract research services from discovery to clinical development extending to post commercial launch.
 
Dr. Mahesh Bhalgat, Group – CEO of Veeda Clinical Research, said, “With the growing emphasis on global clinical trials, this acquisition now positions Veeda to offer access to a very diverse population for conducting large scale multi-geography trials efficiently. Both organizations are focused towards driving equitable access to trials and fostering the development of innovative treatments worldwide. The acquisition brings together a unique team of scientists and researchers, having deep therapeutic area expertise in the Oncology research. This equips Veeda to build long and enduring site relationships across geographies.”
 
Mr. Binoy Gardi, Executive Vice Chairperson of Veeda Clinical Research, said, “As we integrate the operations of both the companies, this is an exciting opportunity for Veeda and Heads to expand markets, leverage complimentary capabilities and add value to our clients. We believe that our combined strengths will enable us to drive greater efficiency, innovation, and excellence in delivering research outcomes for drug development programs of our clients worldwide.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters